All patients | CXCL5 | CXCR2 | |||||
---|---|---|---|---|---|---|---|
n = 107(%) | High (n = 44) | Low (n = 63) | P | High (n = 52) | Low (n = 55) | P | |
Age (year) | |||||||
< 50 | 68(63.6) | 27 | 41 | 0.694 | 30 | 38 | 0.221 |
≥ 50 | 39(36.4) | 17 | 22 | 22 | 17 | ||
Gender | |||||||
Male | 84(78.5) | 35 | 49 | 0.827 | 37 | 47 | 0.072 |
Female | 23(21.5) | 9 | 14 | 15 | 8 | ||
Tumor classification | |||||||
T1–2 | 59(55.1) | 22 | 37 | 0.372 | 27 | 32 | 0.515 |
T3–4 | 48(44.9) | 22 | 26 | 25 | 23 | ||
Nodal classification | |||||||
N0–1 | 78(72.9) | 26 | 52 | 0.007 | 33 | 45 | 0.033 |
N2–3 | 29(27.1) | 18 | 11 | 19 | 10 | ||
Clinical classification | |||||||
I-II | 44(41.1) | 14 | 30 | 0.102 | 20 | 24 | 0.587 |
III-IVb | 63(58.9) | 30 | 33 | 32 | 31 | ||
Local-regional recurrence | |||||||
No | 90(84.1) | 35 | 55 | 0.280 | 46 | 44 | 0.231 |
Yes | 17(15.9) | 9 | 8 | 6 | 11 | ||
Distant metastasis | |||||||
No | 85(79.4) | 32 | 53 | 0.055 | 37 | 48 | 0.039 |
Yes | 22(20.6) | 12 | 10 | 15 | 7 | ||
Progression | |||||||
No | 70(65.4) | 24 | 46 | 0.048 | 32 | 38 | 0.412 |
Yes | 37(34.6) | 20 | 17 | 20 | 17 |